Pharmacology Research & Perspectives

Papers
(The H4-Index of Pharmacology Research & Perspectives is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Pharmacogenomics Education and Knowledge Assessment in Healthcare Curricula: A Scoping Review of the Middle East and North Africa Region111
96
Histamine in cancer immunology and immunotherapy. Current status and new perspectives85
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single‐center observational study57
A Phase 1 first‐in‐human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF‐06730512 in healthy participants51
Benefits and adverse effects of sacubitril/valsartan in patients with chronic heart failure: A systematic review and meta‐analysis48
Chemogenetic stimulation of the Gi pathway in astrocytes suppresses neuroinflammation42
Polypharmacology of clinical sodium glucose co‐transport protein 2 inhibitors and relationship to suspected adverse drug reactions33
Nucleoside analog GS‐441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid‐1931
Patient safety in home care: A multicenter cross‐sectional study about medication errors and medication management of nurses30
Corrigendum30
The potencies and neurotoxicity of intrathecal levobupivacaine in a rat spinal model: Effects of concentration28
The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β‐eudesmol in human liver: Reaction phenotyping and enzyme kinetics27
Synthesis of salcaprozate sodium and its significance in enhancing pancreatic kininogenase absorption performance24
Quantitative analysis of the UDP‐glucuronosyltransferase transcriptome in human tissues23
The blockade of the TGF‐β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesity22
Issue Information21
Monitoring Serum Bisoprolol Concentrations in Patients With Heart Failure With Reduced Ejection Fraction: Results of a Pilot Study From Routine Health Care20
Modeling time‐delayed concentration‐QT effects with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonist19
Endoplasmic reticulum stress in the adipose tissue and monocyte chemoattractant protein‐1 are involved in tacrolimus‐induced diabetes mellitus19
0.070571899414062